The American Society for Radiation Oncology (ASTRO) has issued new guidelines on the appropriate use of stereotactic radiation (SBRT) in early-stage non-small cell lung cancer (NSCLC), now the leading ...
New guidelines on stereotactic body radiotherapy for primary renal cell carcinoma address optimal dosing, the role of biopsy, follow-up practices, and the treatment of patients with a solitary kidney.
SBRT is noninferior to traditional radiation for low- to intermediate-risk localized prostate cancer, offering a viable treatment alternative. The PACE-B study showed a 95.8% five-year rate of no ...
A second course of stereotactic body radiation therapy (SBRT) is an important therapeutic strategy to consider for men with recurrent oligometastatic prostate cancer after an initial course of SBRT, ...
Hosted on MSN
At 10 years, stereotactic body radiation therapy comparable to surgery for early-stage lung cancer
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Magnetic ...
Stereotactic body radiation therapy followed by sorafenib extended survival compared with sorafenib alone among patients with hepatocellular carcinoma, according to study results presented at ASCO ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results